Advance care planning in patients undergoing hematopoietic cell transplantation.
Few data are available on the prevalence of advance care planning (ACP) in patients undergoing hematopoietic cell transplantation (HCT). We surveyed adult patients pre-HCT to ascertain completion of various elements of ACP. We also reviewed medical records for documentation of discussions regarding ACP and for the presence of written advance directives. Evaluable surveys were returned by 155 of 335 patients (46%) who underwent HCT during the study period; we obtained permission for medical record review from 137 of these 155 survey respondents (88%). We found that 69% of the respondents reported having designated a health care proxy, 44% had completed a living will, 61% had prepared an estate will, and 63% had discussed their wishes regarding life support with family and friends. In contrast, only 16% had discussed their wishes regarding life support with their clinicians. Documentation of discussions between clinicians and patients regarding most elements of ACP was rare. Written advance directives were present in the charts of 54 patients (39%). ACP was more common in older, college-educated, and allogeneic transplant patients. Even though ACP was more prevalent among this sample than in the general population, its use still could be enhanced, given the high risks of decisional incapacity and death that HCT patients face.
Joffe
Steven
S
Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts 02115, USA. steven_joffe@dfci.harvard.edu
Mello
Michelle M
MM
Cook
E Francis
EF
Lee
Stephanie J
SJ
D000328:Adult; D032722:Advance Care Planning; D003625:Data Collection; D005260:Female; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D016224:Living Wills; D008137:Longitudinal Studies; D008297:Male; D008499:Medical Records; D008875:Middle Aged; D010817:Physician-Patient Relations; D011795:Surveys and Questionnaires